You are using an outdated browser. Please upgrade your browser to improve your experience.
Turbu+ Insights UK

This application has been developed and funded by AstraZeneca (a private limited company registered in England and Wales under company number 03674842 and with registered offices at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA) who is represented in the U

This application has been developed and funded by AstraZeneca (a private limited company registered in England and Wales under company number 03674842 and with registered offices at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA) who is represented in the U

Turbu+ Insights UK

by AstraZeneca Pharmaceuticals LP
Turbu+ Insights UK
Turbu+ Insights UK
Turbu+ Insights UK

What is it about?

This application has been developed and funded by AstraZeneca (a private limited company registered in England and Wales under company number 03674842 and with registered offices at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA) who is represented in the U.K. by AstraZeneca UK Ltd with offices at Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU. The service is supported by trusted third party vendors, who provide and support the technology. This application is for patients who have been enrolled to use it by their healthcare professional. The main purpose of the application is to help patients manage their prescribed medication in conjunction with their healthcare professional. The application will capture the prescribed dose and medication use data. Based on a patients specific medication use pattern (adherence data), they will receive regular medication reminders and missed medication messages. The application will also help AstraZeneca and its partners to improve the services offered to patients and the NHS. Approval ID: GB-17794/Prep Jul 2019

Turbu+ Insights UK

App Details

Version
2.1.2
Rating
NA
Size
112Mb
Genre
Medical
Last updated
October 11, 2019
Release date
August 29, 2019
More info

App Screenshots

Turbu+ Insights UK screenshot-0
Turbu+ Insights UK screenshot-1
Turbu+ Insights UK screenshot-2
Turbu+ Insights UK screenshot-3

App Store Description

This application has been developed and funded by AstraZeneca (a private limited company registered in England and Wales under company number 03674842 and with registered offices at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA) who is represented in the U.K. by AstraZeneca UK Ltd with offices at Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU. The service is supported by trusted third party vendors, who provide and support the technology. This application is for patients who have been enrolled to use it by their healthcare professional. The main purpose of the application is to help patients manage their prescribed medication in conjunction with their healthcare professional. The application will capture the prescribed dose and medication use data. Based on a patients specific medication use pattern (adherence data), they will receive regular medication reminders and missed medication messages. The application will also help AstraZeneca and its partners to improve the services offered to patients and the NHS. Approval ID: GB-17794/Prep Jul 2019

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.